when excluding the impact of the special items, adjusted earnings per share was a loss $num-one per share.
earnings per share for the quarter was a loss of $num-one per share.
in the medical end-use market, sales were down num-one% sequentially as customers continue to manage inventory levels as concerns around hospital capacity and potential resurgence weighed on the supply chain.
net sales in the second quarter were $num-one million.
for the balance of the year, we currently expect the tax rate to be in the range of num-one% to num-two%.
when excluding the impact of the special items, namely the goodwill impairment charge and the covid costs, adjusted operating loss was $num-one million compared to adjusted operating income of $num-two million in the prior year period and an adjusted operating loss of $num-three million in the first quarter of fiscal year year-six.
sales excluding surcharge decreased num-one% sequentially on a num-two% lower volume.
compared to the second quarter last year, sales excluding surcharge decreased num-one% on num-two% lower volume.
the operating loss was $num-one million in the quarter.
sg&a expenses were $num-one million in the second quarter, down $num-two million from the same period a year ago and flat sequentially.
net sales for the quarter were $num-one million or $num-two million, excluding surcharge.
strong sales have been met with low inventory levels as u.s. vehicle inventory remains below num-one days of supply, down approximately num-two% year-over-year.
net sales, excluding surcharge, were $num-one million, which were down num-two% from the same quarter a year ago and down num-three% sequentially.
compared to the second quarter a year ago, sales decreased num-one% on num-two% lower volume.
when factoring out the disproportionate impact of the goodwill impairment charge on the tax rate, the income tax rate for the quarter would have been approximately num-one%.
our effective tax rate for the second quarter was num-one%.